{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:29:27Z","timestamp":1786429767651,"version":"build-2736575974"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-026-04674-0","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T05:57:15Z","timestamp":1786427835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SMARCB1\/INI1-deficient peripheral T-cell lymphoma: two cases expanding the spectrum of an emerging entity and a review of the literature"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0822-0970","authenticated-orcid":false,"given":"Zhao Jian Oswald","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth DH","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hian Li Esther","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean Angus","family":"MacPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth Tou En","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Hwee","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Yong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-6410","authenticated-orcid":false,"given":"Siok-Bian","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"4674_CR1","unstructured":"WHO Classification of Tumours Editorial Board. WHO Classification of Tumours Online. Lyon: International Agency for Research on Cancer. https:\/\/tumourclassification.iarc.who.int. Accessed 23 Jan 2026"},{"key":"4674_CR2","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1200\/PO.20.00215","volume":"4","author":"MD Kinnaman","year":"2020","unstructured":"Kinnaman MD, Hamill D, Yabe M et al (2020) Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB1. JCO Precis Oncol 4:1280\u20131284","journal-title":"JCO Precis Oncol"},{"key":"4674_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1182\/blood.2023021106","volume":"142","author":"A Saksena","year":"2023","unstructured":"Saksena A, Rajgariah A (2023) A novel case of peripheral T-cell lymphoma, not otherwise specified, with rhabdoid morphology and INI1 loss. Blood 142:675","journal-title":"Blood"},{"key":"4674_CR4","doi-asserted-by":"publisher","first-page":"8571","DOI":"10.1038\/s41467-024-52826-0","volume":"15","author":"A Fischer","year":"2024","unstructured":"Fischer A, Albert TK, Moreno N et al (2024) Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas. Nat Commun 15:8571","journal-title":"Nat Commun"},{"key":"4674_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2026.101015","volume":"39","author":"JR Bledsoe","year":"2026","unstructured":"Bledsoe JR, Ferry JA, Li J et al (2026) Recurrent SWI\/SNF deficiency defines a subset of peripheral T-cell lymphoma with distinct clinicopathologic features. Mod Pathol 39:101015","journal-title":"Mod Pathol"},{"key":"4674_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/his.15454","volume":"88","author":"WY Lee","year":"2026","unstructured":"Lee WY, Kim YS, Li A et al (2026) Expanding the use of T cell receptor beta constant 1 immunohistochemistry in formalin-fixed paraffin-embedded tissues in assessing T cell clonality in mature and immature T cell neoplasms. Histopathology 88:572\u2013582","journal-title":"Histopathology"},{"key":"4674_CR7","doi-asserted-by":"crossref","unstructured":"Goh J, De Mel S, Hoppe MM et al (2022) An ex vivo platform to guide drug combination treatment in relapsed\/refractory lymphoma. Sci Transl Med 14:eabn7824","DOI":"10.1126\/scitranslmed.abn7824"},{"key":"4674_CR8","unstructured":"WHO Classification of Tumours Editorial Board. Peripheral T-cell lymphoma, not otherwise specified. In: WHO Classification of Tumours: Haematolymphoid Tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2022"},{"key":"4674_CR9","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1182\/blood.2019000779","volume":"134","author":"C Amador","year":"2019","unstructured":"Amador C, Greiner TC, Heavican TB et al (2019) Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry. Blood 134:2159\u20132170","journal-title":"Blood"},{"key":"4674_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100646","volume":"38","author":"C Amador","year":"2025","unstructured":"Amador C, Weisenburger DD, Gomez A et al (2025) Refining diagnostic subtypes of peripheral T-cell lymphoma using a multiparameter approach. Mod Pathol 38:100646","journal-title":"Mod Pathol"},{"key":"4674_CR11","unstructured":"WHO Classification of Tumours Editorial Board. Rhabdoid tumour predisposition syndrome. In: WHO Classification of Tumours: Paediatric Tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2022"},{"key":"4674_CR12","doi-asserted-by":"crossref","unstructured":"Kerl K, Ries D, Unland R et al (2013) The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells. BMC Cancer 13:286; 2022","DOI":"10.1186\/1471-2407-13-286"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04674-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04674-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04674-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T05:57:17Z","timestamp":1786427837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04674-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":12,"alternative-id":["4674"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04674-0","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the National Healthcare Group Domain Specific Review Board B with waiver of consent approved for retrospective cases (Case 1) (DSRB number: 2015\/00176). Informed consent for publication, including accompanying images, was obtained from Case 2 patient.","order":1,"name":"Ethics","label":"Ethics approval and consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}